Back to top
Medical marijuana legalization associated with fewer opioid-related hospitalizations

San Diego, CA: The enactment of statewide legislation permitting medical cannabis access by qualified patients is associated with a reduction in opioid-related hospitalization, according to data published online ahead of print in the journal Drug and Alcohol Dependence.

A researcher from the University of California at San Diego assessed the association between medical cannabis laws and hospitalizations related to opioid pain relievers. The author reported both immediate and longer-term reductions in opioid-related hospitalization following changes in law.

“This study demonstrated significant reductions on OPR- (opioid pain reliever) related hospitalizations associated with the implementation of medical marijuana policies. … We found reductions in OPR-related hospitalizations immediately after the year of policy implementation as well as delayed reductions in the third post-policy year.”

The author also dismissed contentions that liberalized marijuana laws were associated with any subsequent increase in marijuana-related hospital admissions, concluding: “While the interpretation of the results should remain cautious, this study suggested that medical marijuana policies were not associated with marijuana-related hospitalizations. Instead, the policies were unintendedly associated with substantial reductions in OPR related hospitalizations.”

The findings are consistent with those of other studies reporting that medical cannabis legalization is associated with lower rates of opioid abusemortality, and prescription drug spending.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever,” appears in Drug and Alcohol Dependence.

Kannabia Seeds Company sells to its customers a product collection, a souvenir. We cannot and we shall not give growing advice since our product is not intended for this purpose.

Kannabia accept no responsibility for any illegal use made by third parties of information published. The cultivation of cannabis for personal consumption is an activity subject to legal restrictions that vary from state to state. We recommend consultation of the legislation in force in your country of residence to avoid participation in any illegal activity.

Comments

Kannabia Seeds Company vend à sa clientèle un produit de collection, un souvenir. Nous ne pouvons pas et nous ne devons pas donner de culture, donc notre produit n’est pas destiné à cette fin.

Kannabia accept no responsibility for any illegal use made by third parties of information published. The cultivation of cannabis for personal consumption is an activity subject to legal restrictions that vary from state to state. We recommend consultation of the legislation in force in your country of residence to avoid participation in any illegal activity.